發(fā)布:2023-11-16 20:04:55 關(guān)注:14991次
今日招聘網(wǎng)事業(yè)單位考試網(wǎng)為各位考生帶來(lái):2023浙江中醫(yī)藥大學(xué)招聘公告(Job Advertisement)。更多浙江事業(yè)單位招聘信息相關(guān)內(nèi)容可查看欄目:浙江事業(yè)編人才招聘公告。
職位名稱:癌細(xì)胞信號(hào)實(shí)驗(yàn)室實(shí)驗(yàn)室管理員(LM)、博士后(PD)和博士(PhD)
Post Title: Lab manager (LM), postdoc (PD) and PhD positions in Cancer Cell Signalling lab
工作單位:浙江中醫(yī)藥大學(xué)(ZCMU)
Employer: Zhejiang Chinese Medical University (ZCMU)
地 點(diǎn):中國(guó) 浙江杭州
Location: Hangzhou, Zhejiang, China
待 遇:醫(yī)院編制,享受五險(xiǎn)一金等福利待遇,由申請(qǐng)人的經(jīng)驗(yàn)和技能水平?jīng)Q定有競(jìng)爭(zhēng)力的獎(jiǎng)金。
Treatment & Salary: All enter the post system. Benefits such as five social insurance and one housing fund, and competitive bonus determined by the level of experience and skill set of the applicants.
截止日期:2024年3月31日
Closing date: 31/03/2024
預(yù)計(jì)工作開(kāi)始日期:2024年5-6月
Expected start date: May/June 2024
職位基本要求:
Essential criteria for Lab manager (LM) / postdoc (PD) and PhD (PhD) posts:
l 優(yōu)秀的中英文書(shū)面及口語(yǔ)能力(LM、PD和PhD)。
Excellent written/spoken knowledge of English and Chinese languages (LM, PD and PhD).
l 生物化學(xué)、分子/細(xì)胞生物學(xué)博士學(xué)位或同等學(xué)歷(LM和PD)。
PhD in biochemistry, molecular/cellular biology or equivalent (LM and PD).
l 以第一作者在知名期刊上至少發(fā)表一篇論文(PD)。
A minimum of one first author publication in a reputable journal (PD).
l 在生物化學(xué)、分子/細(xì)胞和癌癥生物學(xué)技術(shù)方面的高級(jí)技能(LM和PD)。
Advanced skills in biochemistry, molecular/cellular and cancer biology techniques (LM and PD).
l 致力于在一個(gè)競(jìng)爭(zhēng)激烈的領(lǐng)域工作(LM、PD和PhD)。
Commitment to work in a highly competitive field (LM, PD and PhD).
l 具有寫(xiě)科學(xué)論文、基金標(biāo)書(shū)和準(zhǔn)備高質(zhì)量數(shù)據(jù)的能力。
A demonstrated ability to write scientific papers/grants and prepare high-quality figures.
l 能夠獨(dú)立地推動(dòng)一個(gè)研究項(xiàng)目和數(shù)據(jù)分析(PD)。
Ability to independently drive a research project and analyse data (PD).
l 作為一個(gè)團(tuán)隊(duì)的一部分,能夠主動(dòng)地、無(wú)需監(jiān)督地單獨(dú)工作(LM、PD和PhD)。
Ability to work individually on own initiative and without close supervision, and as part of a team (LM PD and PhD).
l 優(yōu)秀的組織、口頭、書(shū)面溝通技巧(LM、PD和PhD)。
Excellent organizational and oral/written communication skills (LM, PD and PhD).
l 能夠優(yōu)先考慮并完成最后期限(LM、PD和PhD)。
Ability to prioritize and meet deadlines (LM, PD and PhD).
l 優(yōu)秀的演示文稿和IT技能(LM、PD和PhD)。
Excellent presentation and IT skills (LM, PD and PhD).
l 準(zhǔn)確和完整的保留實(shí)驗(yàn)室工作記錄(LM、PD和PhD)。
Keeping accurate and complete records of lab work (LM, PD and PhD).
l 誠(chéng)實(shí)、積極、獨(dú)立,嚴(yán)格遵守科研職業(yè)道德(LM、PD和PhD)。
Honesty, motivation, demonstrable independence, commitment and a strong work ethic (LM, PD and PhD).
浙江中醫(yī)藥大學(xué)(濱文校區(qū))新成立的喬治奧斯.賈馬斯(Georgios Giamas)教授的癌癥轉(zhuǎn)化研究實(shí)驗(yàn)室,現(xiàn)有各種研究職位(包括1個(gè)實(shí)驗(yàn)室管理員、1個(gè)博士后和2個(gè)博士職位)招聘。這是一個(gè)積極的、充滿活力的研究小組,提供一個(gè)激勵(lì)性和支持性的研究環(huán)境,致力于卓越的研究,并著力培養(yǎng)學(xué)員和初級(jí)教員的科學(xué)職業(yè)生涯。
Various research positions (including 1x lab manager, 1x postdoctoral and 2x PhD positions) are available in the newly established translational cancer research laboratory of Professor Georgios Giamas at ZCMU (Binwen Campus). We are an active, vibrant research group and provide a stimulating and supportive research environment. We are committed to research excellence and to nurturing scientific careers amongst our trainees and junior faculty.
該實(shí)驗(yàn)室研究項(xiàng)目包括但不限于:
1.在乳腺和腦腫瘤微環(huán)境中識(shí)別新的藥物靶點(diǎn);
2.在基于細(xì)胞外囊泡的液體活檢中識(shí)別實(shí)體腫瘤的生物標(biāo)志物;
3.闡明LMTK3與癌癥和其他疾病/紊亂有關(guān)的信號(hào)通路。
Available research projects include, but are not limited to:
l ‘Identification of novel druggable targets within the breast and brain tumour microenvironments’;
l ‘Identification of solid tumours biomarkers in extracellular vesicles-based liquid biopsies’;
l ‘Elucidation of the signalling pathways that LMTK3 is implicated in, in cancer and other disease/disorders’.
實(shí)驗(yàn)室的科研工作結(jié)合了多種體外、體內(nèi)模型和患者的標(biāo)本來(lái)研究癌癥的相關(guān)途徑。賈馬斯實(shí)驗(yàn)室的研究概述可以在線上找到,網(wǎng)址為:http://www.sussex.ac.uk/lifesci/giamaslab/
Our work combines a variety of in vitro, in vivo models and patients' specimens to study relevant pathways in cancer. An overview of research within the Giamas lab can be found at: http://www.sussex.ac.uk/lifesci/giamaslab/
請(qǐng)聯(lián)系教授喬治奧斯.賈馬斯(g.giamas@sussex.ac.uk)進(jìn)行非正式詢問(wèn)。
Please contact Prof. Georgios Giamas (g,giamas@sussex.ac.uk) for informal enquiries.
正式申請(qǐng)時(shí)請(qǐng)附有一份完整的個(gè)人簡(jiǎn)歷和三名學(xué)術(shù)推薦人的姓名。請(qǐng)將上述材料發(fā)送到喬治奧斯.賈馬斯郵箱(Email: g.giamas@sussex.ac.uk);同步將材料抄送給附屬第一醫(yī)院人事科劉振東老師的郵箱(zjszyyzzrsb@163.com;+86-057187071816)。
Formal applications should be accompanied by a full CV and the names of three academic referees. Please send these materials to Prof. Georgios Giamas (g,giamas@sussex.ac.uk) and CC email to Dr. Zhendong Liu (zjszyyzzrsb@163.com;+86-057187071816).
浙江中醫(yī)藥大學(xué)簡(jiǎn)介:
浙江中醫(yī)藥大學(xué)位于歷史風(fēng)景名城浙江杭州,是浙江省重點(diǎn)建設(shè)高校,是浙江省人民政府、國(guó)家中醫(yī)藥管理局、教育部共建高校。
學(xué)校現(xiàn)有濱文、富春2個(gè)校區(qū),占地千畝,總建筑面積逾47萬(wàn)平方米,現(xiàn)有全日制在校生22000余人,其中碩博士研究生5200余人、學(xué)歷留學(xué)生800余人。學(xué)校是全國(guó)首批招收和培養(yǎng)中醫(yī)藥研究生、在浙江省屬高校中首批獲得博士學(xué)位授予權(quán)和博士后科研流動(dòng)站的院校之一。學(xué)校現(xiàn)有博士學(xué)位點(diǎn)覆蓋中醫(yī)學(xué)、中西醫(yī)結(jié)合、中藥學(xué)3個(gè)一級(jí)學(xué)科;碩士學(xué)位點(diǎn)覆蓋9個(gè)一級(jí)學(xué)科。建有中醫(yī)學(xué)、中藥學(xué)、中西醫(yī)結(jié)合3個(gè)博士后科研流動(dòng)站。學(xué)校是國(guó)家創(chuàng)新人才培養(yǎng)示范基地,學(xué)校是國(guó)家創(chuàng)新人才培養(yǎng)示范基地,自主培養(yǎng)了中國(guó)工程院院士、國(guó)醫(yī)大師、國(guó)家“萬(wàn)人計(jì)劃”科技創(chuàng)新領(lǐng)軍人才、國(guó)家“萬(wàn)人計(jì)劃”教學(xué)名師、973計(jì)劃項(xiàng)目首席科學(xué)家、全國(guó)名中醫(yī)、百千萬(wàn)人才工程國(guó)家級(jí)人選等一大批高層次人才。擁有教育部“長(zhǎng)江學(xué)者”特聘教授、浙江省特級(jí)專家、國(guó)務(wù)院特殊津貼專家、國(guó)家杰出青年科學(xué)基金獲得者、國(guó)家優(yōu)秀青年科學(xué)基金獲得者、中醫(yī)藥高等學(xué)校教學(xué)名師、浙江省國(guó)醫(yī)名師、浙江省“錢(qián)江學(xué)者”特聘教授等一批專家學(xué)者。
學(xué)校全力推進(jìn)學(xué)科建設(shè),不斷提升科技創(chuàng)新和服務(wù)能力。建有2個(gè)國(guó)家中醫(yī)臨床研究基地以及國(guó)家中醫(yī)藥管理局重點(diǎn)實(shí)驗(yàn)室。在浙江省屬高校中首批獲得國(guó)家重點(diǎn)學(xué)科(中醫(yī)臨床基礎(chǔ));中醫(yī)學(xué)、中藥學(xué)入選浙江省第二批重點(diǎn)建設(shè)高校優(yōu)勢(shì)特色學(xué)科;臨床醫(yī)學(xué)、藥理學(xué)與毒理學(xué)、生物學(xué)與生物化學(xué)學(xué)科領(lǐng)域進(jìn)入ESI全球排名前1%;獲浙江省“十三五”一流學(xué)科建設(shè)項(xiàng)目A類(lèi)3個(gè)、B類(lèi)6個(gè)。綜合實(shí)力位居國(guó)內(nèi)中醫(yī)藥院校前列。
進(jìn)入新發(fā)展階段,學(xué)校將秉承“求本遠(yuǎn)志”的校訓(xùn),致力于建設(shè)特色鮮明、守正創(chuàng)新的一流中醫(yī)藥大學(xué)。
浙江中醫(yī)藥大學(xué)情況及可用設(shè)施的信息詳見(jiàn)浙江中醫(yī)藥大學(xué)官網(wǎng)(https://www.zcmu.edu.cn)。
Brief Introduction of ZCMU
Zhejiang Chinese Medical University (ZCMU) is a modern university located near the south bank of Qiantang River, in the city of Hangzhou, a world-famous tourist destination known for its beautiful scenery and rich cultural heritage. ZCMU is a key university in Zhejiang Province, P. R. China, jointly established by the People’s Government of Zhejiang Province, the National Administration of Traditional Chinese Medicine (TCM), and the Ministry of Education of the People’s Republic of China.
The university now has two campuses covering with the total area exceeding 470,000 square meters. ZCMU enrolls over 22,000 full-time students, including over 5,200 doctoral and master degree students, and over 800 international students. ZCMU is among the first batch of universities in China to recruit and cultivate postgraduates of TCM, and takes the lead among Zhejiang provincial universities eligible of awarding doctoral degrees and establishing post-doctoral research stations. Now, ZCMU is a teaching and research-oriented university with TCM and Chinese Materia Medica as its leading subjects, combined with contemporary life science subjects. ZCMU is presently comprised of 18 schools and has 4 directly affiliated hospitals. Moreover, there are additional 21 Hospitals located in different cities of Zhejiang Province indirectly affiliated with ZCMU.
ZCMU is a national demonstration base for cultivating innovative talents. It has independently cultivated a number of high-level talents, including Members of Chinese Academy of Engineering, National Masters of TCM, National “Ten Thousand Talent Program” Leading Talents, Chief Scientist of the 973 Program, and National Famous Doctors of TCM etc. Currently, ZCMU employs 1,300 faculty and staff, and among them, over 330 with senior professional titles, including Members of the Academia Europaea, Distinguished Professors holding the title of “the Cheung Kong Scholar” awarded by the Ministry of Education of P.R.C, recipients of National Natural Science Funds for Distinguished Young Scholar and of National Science Foundation for Excellent Young Scholar Awards, etc.
ZCMU promotes established and new disciplines with emphasis on scientific technology innovation. ZCMU was within the first batch of Zhejiang provincial universities that have been awarded national key discipline. Traditional Chinese Medicine and Chinese Materia Medica are among the second batch of characteristic and preponderant key disciplines of Zhejiang Province. It has 3 A-class and 6 B-class discipline construction programs of Zhejiang “13th Five-Year-Plan”. It has 2 national clinical research bases of TCM and a number of science and innovation platforms. The Research Fields of ZCMU, including Clinical Medicine, Pharmacology and Toxicology, and Biology and Biochemistry, rank at the top 1% of global ranking based on Essential Science Indicators.
In the new era, ZCMU has been and will continue to adhere to the motto of “Seek the Origin at High Aspiration”, and the philosophy of “Student-centered, Academics-prioritized”, and commits to building a first-class TCM university characterized by cultural inheritance and innovation.
More detailed information about the University/available facilities can be find in following link
https://www.zcmu.edu.cn
原標(biāo)題:招聘公告(Job Advertisement)
文章來(lái)源:https://rczp.zcmu.edu.cn/apply/getNotice.action?keycode=271d37b3-8ac4-4978-a34a-a47cb3442778
【1】凡本網(wǎng)注明"來(lái)源:南湖人才網(wǎng)"的所有文字、圖片和音視頻稿件,版權(quán)均屬于南湖人才網(wǎng),轉(zhuǎn)載請(qǐng)必須注明南湖人才網(wǎng),違反者本網(wǎng)將追究相關(guān)法律責(zé)任。
【2】本網(wǎng)轉(zhuǎn)載并注明自其它來(lái)源的作品,是本著為求職者傳遞更多信息之目的,并不代表本網(wǎng)贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性,不承擔(dān)此類(lèi)作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
【3】如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系。
招聘類(lèi)別
其他教職工招聘